Abstract

Simple SummaryAn increased risk of relapse and death from minimally invasive radical hysterectomy has been reported in some patients with early cervical cancer. Thus, the development of an intuitive and precise decision-aid tool, which estimates recurrence and mortality rates by surgical approach, is necessary. To develop models predicting survival outcomes according to the surgical approach, we collected clinicopathologic and survival data of patients with 2009 FIGO stage IB cervical cancer who underwent a radical hysterectomy. Using only variables that could be obtained preoperatively, we developed various models predicting the probability of 5-year progression-free survival and overall survival. Among them, hybrid ensemble models, combined with logistic regression and multiple machine learning models, achieved the best predictive performance. The developed models are expected to help physicians’ and patients’ decision making related to the surgical approach for primary radical hysterectomy.We purposed to develop machine learning models predicting survival outcomes according to the surgical approach for radical hysterectomy (RH) in early cervical cancer. In total, 1056 patients with 2009 FIGO stage IB cervical cancer who underwent primary type C RH by either open or laparoscopic surgery were included in this multicenter retrospective study. The whole dataset consisting of patients’ clinicopathologic data was split into training and test sets with a 4:1 ratio. Using the training set, we developed models predicting the probability of 5-year progression-free survival (PFS) and overall survival (OS) with tenfold cross validation. The developed models were validated in the test set. In terms of predictive performance, we measured the area under the receiver operating characteristic curve (AUC) values. The logistic regression models comprised of preoperative variables yielded AUCs of 0.679 and 0.715 for predicting 5-year PFS and OS rates, respectively. Combining both logistic regression and multiple machine learning models, we constructed hybrid ensemble models, and these models showed much improved predictive performance, with 0.741 and 0.759 AUCs for predicting 5-year PFS and OS rates, respectively. We successfully developed models predicting disease recurrence and mortality after primary RH in patients with early cervical cancer. As the predicted value is calculated based on the preoperative factors, such as the surgical approach, these ensemble models would be useful for making decisions when choosing between open or laparoscopic RH.

Highlights

  • Cervical cancer is the fourth most common female cancer for both incidence and mortality, with an estimated 604,127 new cases and 341,831 cancer deaths worldwide in 2020 [1]

  • This approach declined in popularity after the publication of “Laparoscopic Approach to Carcinoma of the Cervix (LACC)”, a phase III randomized controlled trial (RCT), in 2018 [9]

  • This study aimed to develop hybrid ensemble models predicting the risk of disease recurrence and mortality according to the surgical approach in Federation of Gynecology and Obstetrics (FIGO) stage IB cervical cancer patients

Read more

Summary

Introduction

Cervical cancer is the fourth most common female cancer for both incidence and mortality, with an estimated 604,127 new cases and 341,831 cancer deaths worldwide in 2020 [1]. RH has been commonly performed via minimally invasive surgery (MIS) [7,8] This approach declined in popularity after the publication of “Laparoscopic Approach to Carcinoma of the Cervix (LACC)”, a phase III randomized controlled trial (RCT), in 2018 [9]. This trial reported an increased risk of relapse and death in MIS RH versus conventional open RH (ORH) in patients with the 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IA1 (lymphovascular invasion [LVSI]) to IB1 lesions [9]. Subsequent retrospective studies from different study groups reported inferior survival outcomes with MIS RH [10–17]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call